Home » Topics » Briefs » Other news to note

Other news to note
RSS

Miraculins and Alere shift focus of endoglin program

Feb. 3, 2014

Amgen offers overview of fourth quarter 2013

Jan. 31, 2014

Multiple pivotal phase III trials under way at Array BioPharma

Jan. 31, 2014

Clovis Oncology plans big year for 2014

Jan. 31, 2014

Biogen and UCB sign exclusive agreements to commercialize therapies for MS and hemophilia in Asia

Jan. 30, 2014

Pfizer recaps recent pipeline highlights

Jan. 30, 2014

Gilead Sciences details outlook for 2014

Jan. 30, 2014

Morphosys provides overview of development pipeline

Jan. 30, 2014

Metabolic Pharmaceuticals licenses AOD-9604 to Australian Custom Pharmaceuticals

Jan. 28, 2014

Bristol-Myers Squibb reviews activity of fourth quarter 2013

Jan. 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...